TY - JOUR
T1 - Myocardial Substrate Oxidation and Tricarboxylic Acid Cycle Intermediates During Hypothermic Machine Perfusion
AU - Holmes, Cyonna
AU - Vela, Ryan J.
AU - Powell, La Shondra
AU - Brant, Sarah
AU - Peltz, Matthias
AU - Jessen, Michael E.
N1 - Funding Information:
None of the authors have any relevant financial or personal relationships to disclose. This research was funded by a grant-in-aid from the American Heart Association , South Central Affiliate (# 09GRNT2300004) and a grant from the Miles Foundation (Ft. Worth, TX).
Funding Information:
None of the authors have any relevant financial or personal relationships to disclose. This research was funded by a grant-in-aid from the American Heart Association, South Central Affiliate (# 09GRNT2300004) and a grant from the Miles Foundation (Ft. Worth, TX).
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/3
Y1 - 2021/3
N2 - Background: The optimal substrate for hypothermic machine perfusion preservation of donor hearts is unknown. Fatty acids, acetate, and ketones are preferred substrates of the heart during normothermic perfusion, but cannot replete the tricarboxylic acid (TCA) cycle directly. Propionate, an anaplerotic substrate, can replenish TCA cycle intermediates and may affect cardiac metabolism. The purpose of this study was to determine myocardial substrate preferences during hypothermic machine perfusion and to assess if an anaplerotic substrate was required to maintain the TCA cycle intermediate pool in perfused hearts. Methods: Groups of rat hearts were perfused with carbon-13 (13C)-labeled substrates (acetate, β-hydroxybutyrate, octanoate, with and without propionate) at low and high concentrations. TCA cycle intermediate concentrations, substrate selection, and TCA cycle flux were determined by gas chromatography/mass spectroscopy and 13C magnetic resonance spectroscopy. Results: Acetate and octanoate were preferentially oxidized, whereas β-hydroxybutyrate was a minor substrate. TCA cycle intermediate concentrations except fumarate were higher in substrate-containing perfusion groups compared with either the no-substrate perfusion group or the no-ischemia control group. Conclusions: The presence of an exogenous, oxidizable substrate is required to support metabolism in the cold perfused heart. An anaplerotic substrate is not essential to maintain the TCA cycle intermediate pool and support oxidative metabolism under these conditions.
AB - Background: The optimal substrate for hypothermic machine perfusion preservation of donor hearts is unknown. Fatty acids, acetate, and ketones are preferred substrates of the heart during normothermic perfusion, but cannot replete the tricarboxylic acid (TCA) cycle directly. Propionate, an anaplerotic substrate, can replenish TCA cycle intermediates and may affect cardiac metabolism. The purpose of this study was to determine myocardial substrate preferences during hypothermic machine perfusion and to assess if an anaplerotic substrate was required to maintain the TCA cycle intermediate pool in perfused hearts. Methods: Groups of rat hearts were perfused with carbon-13 (13C)-labeled substrates (acetate, β-hydroxybutyrate, octanoate, with and without propionate) at low and high concentrations. TCA cycle intermediate concentrations, substrate selection, and TCA cycle flux were determined by gas chromatography/mass spectroscopy and 13C magnetic resonance spectroscopy. Results: Acetate and octanoate were preferentially oxidized, whereas β-hydroxybutyrate was a minor substrate. TCA cycle intermediate concentrations except fumarate were higher in substrate-containing perfusion groups compared with either the no-substrate perfusion group or the no-ischemia control group. Conclusions: The presence of an exogenous, oxidizable substrate is required to support metabolism in the cold perfused heart. An anaplerotic substrate is not essential to maintain the TCA cycle intermediate pool and support oxidative metabolism under these conditions.
KW - Cardiac metabolism
KW - Hypothermic machine perfusion preservation
KW - Organ donation
KW - Organ preservation
UR - http://www.scopus.com/inward/record.url?scp=85096864328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096864328&partnerID=8YFLogxK
U2 - 10.1016/j.jss.2020.09.040
DO - 10.1016/j.jss.2020.09.040
M3 - Article
C2 - 33250204
AN - SCOPUS:85096864328
SN - 0022-4804
VL - 259
SP - 242
EP - 252
JO - Journal of Surgical Research
JF - Journal of Surgical Research
ER -